| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6826680 | Schizophrenia Research | 2012 | 6 Pages |
Abstract
Our results suggest that estrogens, especially estradiol, could be an effective augmentation strategy in the treatment of women with schizophrenia. However, future larger trials are needed before recommendations on clinical applications can be made.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Marieke J.H. Begemann, Caroline F. Dekker, Mari van Lunenburg, Iris E. Sommer,